v3.24.1.1.u2
CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (2,562,330) $ (966,561)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of debt discount 605,630 31,650
Stock-based compensation 292,552 272,221
Changes in operating assets and liabilities:    
Accounts payable and accrued expenses 90,994 367,326
Accrued compensation (152,023) 121,995
Due from Chromocell Corporation (45,786)
Prepaid (220,930)
Net Cash Used In Operating Activities (1,991,893) (173,369)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from loan payable - related party, net of debt discount 166,903
Payment of bridge loan, net of debt discount (214,757)
Common stock issued for cash 5,972,000
Recission of common stock (91,512)
Net Cash Provided By Financing Activities 5,665,731 166,903
NET INCREASE (DECREASE) IN CASH 3,673,838 (6,466)
CASH AT BEGINNING OF PERIOD 96,391 55,074
CASH AT END OF PERIOD 3,770,229 48,608
Supplemental cash flow information:    
Cash paid for income taxes
Cash paid for interest expense
NONCASH INVESTING AND FINANCING ACTIVITIES:    
Debt discount from common stock issued for extension of bridge loan 447,779
Conversion of notes 1,362,821
Transfer of liabilities to Chromocell Corp for Preferred Stock $ 2,153,362

Source